Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Company research

Apellis Pharmaceuticals, Inc.

CIK 1492422Updated Nov 16, 2026

Securities
Historical securities (1)APLS · NASDAQ · equity · closed May 14, 2026

APLS price & chart

Provider market data
Historical security

This listing closed May 14, 2026. Live provider charts are shown only for current listings.

About the company

Apellis is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two C3-targeting medicines approved to treat four serious diseases. Breakthroughs for patients include the first-ever therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients 12 and older with C3G or primary IC-MPGN, two severe, rare kidney diseases. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases. For more information, please visit http://apellis.com or follow us on LinkedIn and X.

8-K · 2026-03-31 · 0001193125-26-134916

Company description from the cited filing.

In the news

Seeking Alpha
SEC disclosures

Financials

FY 2025 · USD
Revenue1,003,782,000USD · FY 2025
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

Net income22,388,000USD · FY 2025
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

Operating income55,427,000USD · FY 2025
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

Diluted EPS0.2USD per share · FY 2025
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q3 2023Q2 2025Q2 2024Q1 2026Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD1,058,723,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2025-09-30

901,866,000
Source

10-Q · 2024-11-05 · 0000950170-24-121062

As of 2024-09-30

818,216,000
Source

10-Q · 2023-11-01 · 0000950170-23-057117

As of 2023-09-30

821,390,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2025-06-30

904,482,000
Source

10-Q · 2024-08-01 · 0000950170-24-088938

As of 2024-06-30

1,082,532,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2026-03-31

807,285,000
Source

10-Q · 2025-05-07 · 0000950170-25-064976

As of 2025-03-31

831,930,000
Source

10-Q · 2024-05-07 · 0000950170-24-053921

As of 2024-03-31

1,075,257,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

As of 2025-12-31

885,051,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

As of 2024-12-31

788,730,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

As of 2023-12-31

760,217,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

As of 2022-12-31

Property, Plant and Equipment, NetUSD1,927,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2025-09-30

3,379,000
Source

10-Q · 2024-11-05 · 0000950170-24-121062

As of 2024-09-30

4,790,000
Source

10-Q · 2023-11-01 · 0000950170-23-057117

As of 2023-09-30

2,117,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2025-06-30

3,836,000
Source

10-Q · 2024-08-01 · 0000950170-24-088938

As of 2024-06-30

1,418,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2026-03-31

2,514,000
Source

10-Q · 2025-05-07 · 0000950170-25-064976

As of 2025-03-31

4,195,000
Source

10-Q · 2024-05-07 · 0000950170-24-053921

As of 2024-03-31

1,708,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

As of 2025-12-31

2,952,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

As of 2024-12-31

4,345,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

As of 2023-12-31

6,148,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

As of 2022-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD479,171,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2025-09-30

396,864,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2024-09-30

452,414,000
Source

10-Q · 2024-11-05 · 0000950170-24-121062

As of 2023-09-30

370,036,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2025-06-30

360,087,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2024-06-30

405,207,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2026-03-31

358,393,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2025-03-31

325,923,000
Source

10-Q · 2025-05-07 · 0000950170-25-064976

As of 2024-03-31

466,233,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

As of 2025-12-31

411,290,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

As of 2024-12-31

351,185,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

As of 2023-12-31

551,801,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

As of 2022-12-31

Accounts Receivable, after Allowance for Credit Loss, CurrentUSD345,538,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2025-09-30

279,011,000
Source

10-Q · 2024-11-05 · 0000950170-24-121062

As of 2024-09-30

169,258,000
Source

10-Q · 2023-11-01 · 0000950170-23-057117

As of 2023-09-30

214,131,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2025-06-30

304,433,000
Source

10-Q · 2024-08-01 · 0000950170-24-088938

As of 2024-06-30

440,299,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2026-03-31

235,246,000
Source

10-Q · 2025-05-07 · 0000950170-25-064976

As of 2025-03-31

267,837,000
Source

10-Q · 2024-05-07 · 0000950170-24-053921

As of 2024-03-31

366,221,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

As of 2025-12-31

264,926,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

As of 2024-12-31

206,442,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

As of 2023-12-31

7,727,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

As of 2022-12-31

Inventory, NetUSD122,819,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2025-09-30

121,058,000
Source

10-Q · 2024-11-05 · 0000950170-24-121062

As of 2024-09-30

98,545,000
Source

10-Q · 2023-11-01 · 0000950170-23-057117

As of 2023-09-30

121,000,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2025-06-30

152,772,000
Source

10-Q · 2024-08-01 · 0000950170-24-088938

As of 2024-06-30

131,408,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2026-03-31

82,468,000
Source

10-Q · 2025-05-07 · 0000950170-25-064976

As of 2025-03-31

161,283,000
Source

10-Q · 2024-05-07 · 0000950170-24-053921

As of 2024-03-31

142,556,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

As of 2025-12-31

81,404,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

As of 2024-12-31

146,362,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

As of 2023-12-31

85,714,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

As of 2022-12-31

Assets, CurrentUSD990,676,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2025-09-30

833,897,000
Source

10-Q · 2024-11-05 · 0000950170-24-121062

As of 2024-09-30

796,767,000
Source

10-Q · 2023-11-01 · 0000950170-23-057117

As of 2023-09-30

755,610,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2025-06-30

859,974,000
Source

10-Q · 2024-08-01 · 0000950170-24-088938

As of 2024-06-30

1,028,021,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2026-03-31

727,718,000
Source

10-Q · 2025-05-07 · 0000950170-25-064976

As of 2025-03-31

811,428,000
Source

10-Q · 2024-05-07 · 0000950170-24-053921

As of 2024-03-31

1,014,840,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

As of 2025-12-31

788,954,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

As of 2024-12-31

766,331,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

As of 2023-12-31

719,523,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

As of 2022-12-31

Prepaid Expense and Other Assets, CurrentUSD—————49,587,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2026-03-31

——38,303,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

As of 2025-12-31

———
Operating Lease, Right-of-Use AssetUSD19,720,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2025-09-30

17,060,000
Source

10-Q · 2024-11-05 · 0000950170-24-121062

As of 2024-09-30

15,484,000
Source

10-Q · 2023-11-01 · 0000950170-23-057117

As of 2023-09-30

14,637,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2025-06-30

16,321,000
Source

10-Q · 2024-08-01 · 0000950170-24-088938

As of 2024-06-30

18,945,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2026-03-31

15,251,000
Source

10-Q · 2025-05-07 · 0000950170-25-064976

As of 2025-03-31

14,994,000
Source

10-Q · 2024-05-07 · 0000950170-24-053921

As of 2024-03-31

18,195,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

As of 2025-12-31

16,083,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

As of 2024-12-31

16,745,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

As of 2023-12-31

18,747,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

As of 2022-12-31

Other Assets, NoncurrentUSD5,491,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2025-09-30

1,450,000
Source

10-Q · 2024-11-05 · 0000950170-24-121062

As of 2024-09-30

1,175,000
Source

10-Q · 2023-11-01 · 0000950170-23-057117

As of 2023-09-30

898,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2025-06-30

1,330,000
Source

10-Q · 2024-08-01 · 0000950170-24-088938

As of 2024-06-30

5,659,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2026-03-31

1,150,000
Source

10-Q · 2025-05-07 · 0000950170-25-064976

As of 2025-03-31

1,313,000
Source

10-Q · 2024-05-07 · 0000950170-24-053921

As of 2024-03-31

5,555,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

As of 2025-12-31

1,349,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

As of 2024-12-31

1,309,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

As of 2023-12-31

15,799,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

As of 2022-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD657,555,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2025-09-30

664,745,000
Source

10-Q · 2024-11-05 · 0000950170-24-121062

As of 2024-09-30

585,945,000
Source

10-Q · 2023-11-01 · 0000950170-23-057117

As of 2023-09-30

665,085,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2025-06-30

640,155,000
Source

10-Q · 2024-08-01 · 0000950170-24-088938

As of 2024-06-30

667,609,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2026-03-31

643,069,000
Source

10-Q · 2025-05-07 · 0000950170-25-064976

As of 2025-03-31

565,254,000
Source

10-Q · 2024-05-07 · 0000950170-24-053921

As of 2024-03-31

705,110,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

As of 2025-12-31

656,512,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

As of 2024-12-31

594,209,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

As of 2023-12-31

590,345,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

As of 2022-12-31

Stockholders’ equity:
Preferred Stock, Value, IssuedUSD0
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2025-09-30

0
Source

10-Q · 2024-11-05 · 0000950170-24-121062

As of 2024-09-30

0
Source

10-Q · 2023-11-01 · 0000950170-23-057117

As of 2023-09-30

0
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2025-06-30

0
Source

10-Q · 2024-08-01 · 0000950170-24-088938

As of 2024-06-30

0
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2026-03-31

—0
Source

10-Q · 2024-05-07 · 0000950170-24-053921

As of 2024-03-31

0
Source

10-K · 2026-02-24 · 0001193125-26-065179

As of 2025-12-31

0
Source

10-K · 2025-02-28 · 0000950170-25-029507

As of 2024-12-31

0
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

As of 2023-12-31

0
Source

10-K · 2023-02-21 · 0000950170-23-003438

As of 2022-12-31

Common Stock, Value, IssuedUSD12,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2025-09-30

12,000
Source

10-Q · 2024-11-05 · 0000950170-24-121062

As of 2024-09-30

12,000
Source

10-Q · 2023-11-01 · 0000950170-23-057117

As of 2023-09-30

12,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2025-06-30

12,000
Source

10-Q · 2024-08-01 · 0000950170-24-088938

As of 2024-06-30

13,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2026-03-31

12,000
Source

10-Q · 2025-05-07 · 0000950170-25-064976

As of 2025-03-31

12,000
Source

10-Q · 2024-05-07 · 0000950170-24-053921

As of 2024-03-31

12,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

As of 2025-12-31

12,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

As of 2024-12-31

12,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

As of 2023-12-31

11,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

As of 2022-12-31

Additional Paid in CapitalUSD3,357,583,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2025-09-30

3,239,262,000
Source

10-Q · 2024-11-05 · 0000950170-24-121062

As of 2024-09-30

2,982,236,000
Source

10-Q · 2023-11-01 · 0000950170-23-057117

As of 2023-09-30

3,328,604,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2025-06-30

3,209,245,000
Source

10-Q · 2024-08-01 · 0000950170-24-088938

As of 2024-06-30

3,411,643,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2026-03-31

3,294,849,000
Source

10-Q · 2025-05-07 · 0000950170-25-064976

As of 2025-03-31

3,174,100,000
Source

10-Q · 2024-05-07 · 0000950170-24-053921

As of 2024-03-31

3,385,216,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

As of 2025-12-31

3,267,201,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

As of 2024-12-31

3,035,539,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

As of 2023-12-31

2,479,596,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD-2,954,027,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2025-09-30

-2,999,013,000
Source

10-Q · 2024-11-05 · 0000950170-24-121062

As of 2024-09-30

-2,748,912,000
Source

10-Q · 2023-11-01 · 0000950170-23-057117

As of 2023-09-30

-3,169,742,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2025-06-30

-2,941,568,000
Source

10-Q · 2024-08-01 · 0000950170-24-088938

As of 2024-06-30

-2,994,322,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2026-03-31

-3,127,591,000
Source

10-Q · 2025-05-07 · 0000950170-25-064976

As of 2025-03-31

-2,903,911,000
Source

10-Q · 2024-05-07 · 0000950170-24-053921

As of 2024-03-31

-3,012,978,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

As of 2025-12-31

-3,035,366,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

As of 2024-12-31

-2,837,488,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

As of 2023-12-31

-2,308,860,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

As of 2022-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD-2,400,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2025-09-30

-3,140,000
Source

10-Q · 2024-11-05 · 0000950170-24-121062

As of 2024-09-30

-1,065,000
Source

10-Q · 2023-11-01 · 0000950170-23-057117

As of 2023-09-30

-2,569,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2025-06-30

-3,362,000
Source

10-Q · 2024-08-01 · 0000950170-24-088938

As of 2024-06-30

-2,411,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2026-03-31

-3,054,000
Source

10-Q · 2025-05-07 · 0000950170-25-064976

As of 2025-03-31

-3,525,000
Source

10-Q · 2024-05-07 · 0000950170-24-053921

As of 2024-03-31

-2,103,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

As of 2025-12-31

-3,308,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

As of 2024-12-31

-3,542,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

As of 2023-12-31

-875,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD401,168,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2025-09-30

237,121,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2024-09-30

232,271,000
Source

10-Q · 2024-11-05 · 0000950170-24-121062

As of 2023-09-30

156,305,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2025-06-30

264,327,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2024-06-30

414,923,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2026-03-31

164,216,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2025-03-31

266,676,000
Source

10-Q · 2025-05-07 · 0000950170-25-064976

As of 2024-03-31

370,147,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

As of 2025-12-31

228,539,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

As of 2024-12-31

194,521,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

As of 2023-12-31

169,872,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

As of 2022-12-31

Liabilities and EquityUSD1,058,723,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2025-09-30

901,866,000
Source

10-Q · 2024-11-05 · 0000950170-24-121062

As of 2024-09-30

818,216,000
Source

10-Q · 2023-11-01 · 0000950170-23-057117

As of 2023-09-30

821,390,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2025-06-30

904,482,000
Source

10-Q · 2024-08-01 · 0000950170-24-088938

As of 2024-06-30

1,082,532,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2026-03-31

807,285,000
Source

10-Q · 2025-05-07 · 0000950170-25-064976

As of 2025-03-31

831,930,000
Source

10-Q · 2024-05-07 · 0000950170-24-053921

As of 2024-03-31

1,075,257,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

As of 2025-12-31

885,051,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

As of 2024-12-31

788,730,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

As of 2023-12-31

760,217,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD279,527,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2025-09-30

191,260,000
Source

10-Q · 2024-11-05 · 0000950170-24-121062

As of 2024-09-30

185,630,000
Source

10-Q · 2023-11-01 · 0000950170-23-057117

As of 2023-09-30

200,659,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2025-06-30

169,168,000
Source

10-Q · 2024-08-01 · 0000950170-24-088938

As of 2024-06-30

283,448,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2026-03-31

178,377,000
Source

10-Q · 2025-05-07 · 0000950170-25-064976

As of 2025-03-31

215,291,000
Source

10-Q · 2024-05-07 · 0000950170-24-053921

As of 2024-03-31

323,596,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

As of 2025-12-31

185,509,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

As of 2024-12-31

247,593,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

As of 2023-12-31

167,610,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

As of 2022-12-31

Operating Lease, Liability, CurrentUSD7,022,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2025-09-30

6,792,000
Source

10-Q · 2024-11-05 · 0000950170-24-121062

As of 2024-09-30

5,739,000
Source

10-Q · 2023-11-01 · 0000950170-23-057117

As of 2023-09-30

7,419,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2025-06-30

6,214,000
Source

10-Q · 2024-08-01 · 0000950170-24-088938

As of 2024-06-30

6,962,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2026-03-31

6,944,000
Source

10-Q · 2025-05-07 · 0000950170-25-064976

As of 2025-03-31

6,257,000
Source

10-Q · 2024-05-07 · 0000950170-24-053921

As of 2024-03-31

7,087,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

As of 2025-12-31

6,753,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

As of 2024-12-31

6,441,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

As of 2023-12-31

5,625,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

As of 2022-12-31

Accounts Payable, CurrentUSD38,602,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2025-09-30

42,730,000
Source

10-Q · 2024-11-05 · 0000950170-24-121062

As of 2024-09-30

18,192,000
Source

10-Q · 2023-11-01 · 0000950170-23-057117

As of 2023-09-30

54,241,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2025-06-30

38,270,000
Source

10-Q · 2024-08-01 · 0000950170-24-088938

As of 2024-06-30

49,049,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2026-03-31

55,287,000
Source

10-Q · 2025-05-07 · 0000950170-25-064976

As of 2025-03-31

26,788,000
Source

10-Q · 2024-05-07 · 0000950170-24-053921

As of 2024-03-31

56,798,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

As of 2025-12-31

38,572,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

As of 2024-12-31

37,516,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

As of 2023-12-31

37,342,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

As of 2022-12-31

Operating Lease, Liability, NoncurrentUSD13,680,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2025-09-30

11,411,000
Source

10-Q · 2024-11-05 · 0000950170-24-121062

As of 2024-09-30

10,880,000
Source

10-Q · 2023-11-01 · 0000950170-23-057117

As of 2023-09-30

8,313,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2025-06-30

11,085,000
Source

10-Q · 2024-08-01 · 0000950170-24-088938

As of 2024-06-30

12,807,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2026-03-31

9,186,000
Source

10-Q · 2025-05-07 · 0000950170-25-064976

As of 2025-03-31

9,770,000
Source

10-Q · 2024-05-07 · 0000950170-24-053921

As of 2024-03-31

11,947,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

As of 2025-12-31

10,201,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

As of 2024-12-31

11,454,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

As of 2023-12-31

14,352,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

As of 2022-12-31

Other Liabilities, NoncurrentUSD3,257,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2025-09-30

9,829,000
Source

10-Q · 2024-11-05 · 0000950170-24-121062

As of 2024-09-30

946,000
Source

10-Q · 2023-11-01 · 0000950170-23-057117

As of 2023-09-30

2,078,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2025-06-30

2,691,000
Source

10-Q · 2024-08-01 · 0000950170-24-088938

As of 2024-06-30

9,111,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2026-03-31

2,084,000
Source

10-Q · 2025-05-07 · 0000950170-25-064976

As of 2025-03-31

2,658,000
Source

10-Q · 2024-05-07 · 0000950170-24-053921

As of 2024-03-31

7,903,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

As of 2025-12-31

7,972,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

As of 2024-12-31

2,312,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

As of 2023-12-31

—
Additional Financial Items
Accrued Liabilities, CurrentUSD140,322,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2025-09-30

139,835,000
Source

10-Q · 2024-11-05 · 0000950170-24-121062

As of 2024-09-30

117,089,000
Source

10-Q · 2023-11-01 · 0000950170-23-057117

As of 2023-09-30

138,999,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2025-06-30

122,781,000
Source

10-Q · 2024-08-01 · 0000950170-24-088938

As of 2024-06-30

133,693,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2026-03-31

116,146,000
Source

10-Q · 2025-05-07 · 0000950170-25-064976

As of 2025-03-31

101,399,000
Source

10-Q · 2024-05-07 · 0000950170-24-053921

As of 2024-03-31

166,049,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

As of 2025-12-31

140,184,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

As of 2024-12-31

127,806,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

As of 2023-12-31

95,139,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

As of 2022-12-31

Long-term DebtUSD——92,957,000
Source

10-Q · 2023-11-01 · 0000950170-23-057117

As of 2023-09-30

————93,109,000
Source

10-Q · 2024-05-07 · 0000950170-24-053921

As of 2024-03-31

——93,033,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

As of 2023-12-31

92,736,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

As of 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2025Q2 2024Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD——————18,656,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

-92,225,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

22,388,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

-197,878,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

-528,628,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

-652,172,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Adjustments to reconcile net income to net cash provided by operating activities:
Share-based Payment Arrangement, Noncash ExpenseUSD——————25,173,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

27,374,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

104,003,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

114,128,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

105,945,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

91,085,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts ReceivableUSD——————74,068,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

-29,680,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

101,279,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

58,484,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

198,715,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

-2,375,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Increase (Decrease) in InventoriesUSD——————-18,806,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

-13,997,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

15,267,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

10,755,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

60,647,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

69,397,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Increase (Decrease) in Accounts PayableUSD——————-7,741,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

16,711,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

18,223,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

1,089,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

170,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

18,689,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD——————-60,966,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

-53,410,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

45,327,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

-87,866,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

-594,735,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

-513,745,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD———————-8,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

-313,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

-403,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

-674,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

59,893,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Payments to Acquire Property, Plant, and EquipmentUSD———————8,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

313,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

403,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

773,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

1,524,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Cash flows from financing activities:
Payment, Tax Withholding, Share-based Payment ArrangementUSD——————22,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

7,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

11,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

57,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

11,040,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

5,682,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Financing ActivitiesUSD——————64,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

274,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

8,884,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

149,241,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

394,499,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

365,659,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————-61,033,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

-52,785,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

55,148,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

60,313,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

-200,775,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

-88,681,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD——480,601,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2025-09-30

398,237,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

As of 2024-09-30

371,466,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2025-06-30

361,426,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

As of 2024-06-30

406,727,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2026-03-31

359,827,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

As of 2025-03-31

467,760,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

As of 2025-12-31

412,612,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

As of 2024-12-31

352,299,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

As of 2023-12-31

553,074,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

As of 2022-12-31

Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD——————10,476,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

11,092,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

41,233,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

29,368,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

3,286,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

5,003,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Income Taxes Paid, NetUSD————————1,631,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

——4,915,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD——————-131,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

359,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

1,250,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

-659,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

135,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

-488,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD————————104,003,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

114,128,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

105,945,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

91,085,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

DepreciationUSD——————291,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

446,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

1,558,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

1,797,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

1,784,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

1,552,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Gain (Loss) on Disposition of AssetsUSD——————————-120,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

—
General and Administrative ExpenseUSD——————————500,815,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

277,163,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD——602,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2025-07-01 to 2025-09-30

592,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2024-07-01 to 2024-09-30

466,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2025-04-01 to 2025-06-30

114,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2024-04-01 to 2024-06-30

496,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

341,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

1,722,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

1,162,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

2,132,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

669,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

InterestExpenseNonoperatingUSD——11,279,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2025-07-01 to 2025-09-30

12,532,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2024-07-01 to 2024-09-30

11,152,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2025-04-01 to 2025-06-30

9,359,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2024-04-01 to 2024-06-30

10,317,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

11,049,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

44,327,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

40,391,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

——
Inventory Write-downUSD——————20,000,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

23,400,000
Source

10-Q · 2025-05-07 · 0000950170-25-064976

2025-01-01 to 2025-03-31

20,500,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

19,000,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

6,400,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

—
Net Income (Loss) Attributable to ParentUSD——215,715,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2025-07-01 to 2025-09-30

-57,445,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2024-07-01 to 2024-09-30

-42,151,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2025-04-01 to 2025-06-30

-37,657,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2024-04-01 to 2024-06-30

18,656,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

-92,225,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

22,388,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

-197,878,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

-528,628,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

-652,172,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Operating ExpensesUSD——235,395,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2025-07-01 to 2025-09-30

244,110,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2024-07-01 to 2024-09-30

211,780,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2025-04-01 to 2025-06-30

229,128,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2024-04-01 to 2024-06-30

241,828,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

250,125,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

948,355,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

946,346,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

913,712,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

670,035,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Other Nonoperating Income (Expense)USD——37,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2025-07-01 to 2025-09-30

70,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2024-07-01 to 2024-09-30

146,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2025-04-01 to 2025-06-30

24,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2024-04-01 to 2024-06-30

88,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

-165,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

-133,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

-2,170,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

-727,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

-288,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Proceeds from Issuance of Common StockUSD———————————380,120,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD———————————393,280,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Proceeds from Stock Options ExercisedUSD——————86,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

281,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

5,545,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

14,316,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

71,274,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

—
Share-based Payment Arrangement, Expensed and Capitalized, AmountUSD————————109,131,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

———

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2025Q2 2024Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Total RevenueUSD——458,578,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2025-07-01 to 2025-09-30

196,830,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2024-07-01 to 2024-09-30

178,494,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2025-04-01 to 2025-06-30

199,685,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2024-04-01 to 2024-06-30

268,295,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

166,797,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

1,003,782,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

781,367,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

396,591,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

75,422,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Selling, General and Administrative ExpenseUSD——142,678,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2025-07-01 to 2025-09-30

121,984,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2024-07-01 to 2024-09-30

131,139,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2025-04-01 to 2025-06-30

128,081,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2024-04-01 to 2024-06-30

124,323,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

129,345,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

550,265,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

501,053,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

——
Operating Income (Loss)USD——223,183,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2025-07-01 to 2025-09-30

-47,280,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2024-07-01 to 2024-09-30

-33,286,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2025-04-01 to 2025-06-30

-29,443,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2024-04-01 to 2024-06-30

26,467,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

-83,328,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

55,427,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

-164,979,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

-517,121,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

-594,613,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Other Nonoperating Income (Expense)USD——37,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2025-07-01 to 2025-09-30

70,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2024-07-01 to 2024-09-30

146,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2025-04-01 to 2025-06-30

24,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2024-04-01 to 2024-06-30

88,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

-165,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

-133,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

-2,170,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

-727,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

-288,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD——216,317,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2025-07-01 to 2025-09-30

-56,853,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2024-07-01 to 2024-09-30

-41,685,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2025-04-01 to 2025-06-30

-37,543,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2024-04-01 to 2024-06-30

19,152,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

-91,884,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

24,110,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

-196,716,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

-526,496,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

-651,503,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD——602,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2025-07-01 to 2025-09-30

592,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2024-07-01 to 2024-09-30

466,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2025-04-01 to 2025-06-30

114,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2024-04-01 to 2024-06-30

496,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

341,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

1,722,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

1,162,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

2,132,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

669,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——215,715,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2025-07-01 to 2025-09-30

-57,445,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2024-07-01 to 2024-09-30

-42,151,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2025-04-01 to 2025-06-30

-37,657,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2024-04-01 to 2024-06-30

18,656,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

-92,225,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

22,388,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

-197,878,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

-528,628,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

-652,172,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share——1.71
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2025-07-01 to 2025-09-30

-0.46
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2024-07-01 to 2024-09-30

-0.33
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2025-04-01 to 2025-06-30

-0.3
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2024-04-01 to 2024-06-30

0.15
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

-0.74
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

0.18
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

-1.6
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

-4.45
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

-6.15
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share——1.67
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2025-07-01 to 2025-09-30

-0.46
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2024-07-01 to 2024-09-30

-0.33
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2025-04-01 to 2025-06-30

-0.3
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2024-04-01 to 2024-06-30

0.15
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

-0.74
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

0.2
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

-1.6
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

-4.45
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

-6.15
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Basicshares——126,424,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2025-07-01 to 2025-09-30

124,234,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2024-07-01 to 2024-09-30

126,024,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2025-04-01 to 2025-06-30

123,904,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2024-04-01 to 2024-06-30

127,682,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

125,453,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

126,145,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

123,905,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

118,678,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

106,114,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares——130,067,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2025-07-01 to 2025-09-30

124,234,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2024-07-01 to 2024-09-30

126,024,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2025-04-01 to 2025-06-30

123,904,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2024-04-01 to 2024-06-30

131,424,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

125,453,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

129,855,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

123,905,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

118,678,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

106,114,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Interest Expense (non-operating)USD——11,279,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2025-07-01 to 2025-09-30

12,532,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2024-07-01 to 2024-09-30

11,152,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2025-04-01 to 2025-06-30

9,359,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2024-04-01 to 2024-06-30

10,317,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

11,049,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

44,327,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

40,391,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

——
Additional Financial Items
Current Income Tax Expense (Benefit)USD————————1,722,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

1,162,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

2,132,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

669,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD——————————500,815,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

277,163,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD————————-120,516,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

-22,701,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

-48,495,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

-82,815,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Operating ExpensesUSD——235,395,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2025-07-01 to 2025-09-30

244,110,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2024-07-01 to 2024-09-30

211,780,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2025-04-01 to 2025-06-30

229,128,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2024-04-01 to 2024-06-30

241,828,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

250,125,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

948,355,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

946,346,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

913,712,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

670,035,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Research and Development ExpenseUSD——68,186,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2025-07-01 to 2025-09-30

88,569,000
Source

10-Q · 2025-10-30 · 0001193125-25-257374

2024-07-01 to 2024-09-30

67,015,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2025-04-01 to 2025-06-30

77,947,000
Source

10-Q · 2025-07-31 · 0000950170-25-100545

2024-04-01 to 2024-06-30

76,958,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2026-01-01 to 2026-03-31

86,420,000
Source

10-Q · 2026-05-07 · 0001492422-26-000108

2025-01-01 to 2025-03-31

295,854,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

327,570,000
Source

10-K · 2025-02-28 · 0000950170-25-029507

2024-01-01 to 2024-12-31

354,387,000
Source

10-K/A · 2024-02-29 · 0000950170-24-023256

2023-01-01 to 2023-12-31

387,236,000
Source

10-K · 2023-02-21 · 0000950170-23-003438

2022-01-01 to 2022-12-31

Share-based Payment Arrangement, Expensed and Capitalized, AmountUSD————————109,131,000
Source

10-K · 2026-02-24 · 0001193125-26-065179

2025-01-01 to 2025-12-31

———

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

d23709dex41.htm · 8-K · 2026-05-14

EX-4.1 4 d23709dex41.htm EX-4.1 EX-4.1 Exhibit 4.1 FIRST SUPPLEMENTAL INDENTURE This First Supplemental Indenture (this “Supplemental Indenture”) is made and entered into as of May 14, 2026, among Apellis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Biogen Inc., a Delaware corporation (“Parent”), and U.S. Bank Trust Company, National Association, as successor in interest to U.S. Bank National Association, as trustee (the “Trustee”). RECITALS WHEREAS, the Company and th…

8-K · 2026-05-14 · 0001193125-26-222923

Read attachment ↗
d23709dex991.htm · 8-K · 2026-05-14

EX-99.1 6 d23709dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 May 14, 2026 U.S. Bank Trust Company, National Association Global Corporate Trust One Federal Street, 10th Floor Boston, MA 02110 Attention: James Byrnes The Depository Trust Company Announcements Department 140 58th Street Brooklyn, NY 11220 Attention: Announcement Department Re: Apellis Pharmaceuticals, Inc. – Notice of Supplemental Indenture, Fundamental Change and Make-Whole Fundamental Change to Trust…

8-K · 2026-05-14 · 0001193125-26-222923

Read attachment ↗
d130703dex991.htm · SC14D9C · 2026-04-06

Exhibit 99.1 Intranet FAQ About the deal What was announced? Apellis and Biogen have entered into an agreement under which Biogen has agreed to acquire all outstanding shares of Apellis for $41 per share in cash at closing, representing a total value of approximately $5.6 billion. Apellis stockholders will also receive a nontransferable contingent value right (CVR) for each Apellis share held, entitling the holder to receive additional cash payments if certain annual sales thresho…

SC14D9C · 2026-04-06 · 0001193125-26-143698

Read attachment ↗
d133397dex992.htm · SC14D9C · 2026-03-31

Exhibit 99.2 Subject: Apellis to be acquired by Biogen Dear Apellucians, Today, we announced that Apellis has agreed to be acquired by Biogen, a global biotechnology company, for $41 per share in cash, representing a total value of approximately $5.6 billion. There is also upside potential with the contingent value right (CVR), which would deliver two additional cash payments to shareholders if certain annual sales thresholds for SYFOVRE are met. This deal reflects the transformational impac…

SC14D9C · 2026-03-31 · 0001193125-26-135019

Read attachment ↗
d132653dex991.htm · 8-K · 2026-03-31

EX-99.1 3 d132653dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 TENDER AND SUPPORT AGREEMENT This TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of March 31, 2026, is by and among Biogen Inc., a Delaware corporation (“Parent”), Aspen Purchaser Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Purchaser”), and each stockholder listed on the signature pages hereto (each, a “Stockholder”). WHEREAS, each Stockholder is, as of the date hereof, the record or benef…

8-K · 2026-03-31 · 0001193125-26-134916

Read attachment ↗
d132653dex992.htm · 8-K · 2026-03-31

EX-99.2 4 d132653dex992.htm EX-99.2 EX-99.2 Exhibit 99.2 Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology Acquisition will bring two differentiated commercialized immunology medicines to Biogen with EMPAVELI® FDA-approved in three indications, including two rare kidney diseases, and SYFOVRE® FDA-approved in geographic atrophy, an immune-mediated retinal disease Bri…

8-K · 2026-03-31 · 0001193125-26-134916

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.